Alkermes Plc (ALKS)

28.50 -0.78 (-2.66%) USD  |  NASDAQ  |  Mar 05, 12:00
More

Alkermes Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for ALKS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Avadel Pharmaceuticals Plc Upgrade
Krystal Biotech, Inc. Upgrade
Assertio Holdings, Inc. Upgrade
Amarin Corp. Plc Upgrade
Amicus Therapeutics, Inc. Upgrade